Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Alzheimer'S Research & Therapy|November 5, 2018
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's diseaseRaquel Sánchez-Valle, Amanda Heslegrave, Martha S Foiani, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2018
Amyloid β peptides are differentially vulnerable to preanalytical surface exposure, an effect incompletely mitigated by the use of ratiosJamie Toombs, Martha S Foiani, Henrietta Wellington, et al.
Journal of Alzheimer'S Disease : JAD|January 7, 2017
Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β ConcentrationJamie Toombs, Martha S Foiani, Ross W Paterson, et al.
Scientific Reports|February 11, 2021
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's diseaseZhen-Yi Andy Ou, Lauren M Byrne, Filipe B Rodrigues, et al.
Journal of Neurology|July 22, 2021
Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysisGargi Banerjee, Niklas Forsgard, Gareth Ambler, et al.
Alzheimer'S Research & Therapy|December 19, 2019
CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementiaMica T M Clarke, Ann Brinkmalm, Martha S Foiani, et al.
Dementia and Geriatric Cognitive Disorders|April 29, 2020
Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological SubtypeIone O C Woollacott, Jennifer M Nicholas, Carolin Heller, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 15, 2018
Plasma tau is increased in frontotemporal dementiaMartha S Foiani, Ione Oc Woollacott, Carolin Heller, et al.
Journal of Alzheimer'S Disease : JAD|March 17, 2020
Cerebrospinal Fluid Biomarkers in Cerebral Amyloid AngiopathyGargi Banerjee, Gareth Ambler, Ashvini Keshavan, et al.
Alzheimer'S Research & Therapy|August 17, 2018
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroupIone O C Woollacott, Jennifer M Nicholas, Amanda Heslegrave, et al.
Pageof 2